The Circadian Clock in Cancer Development and Therapy - Progress in Molecular Biology and Translational Science - page 271

234. van de Wetering M, de Lau W, Clevers H. WNT signaling and lymphocyte develop-
ment. Cell . 2002;109(Suppl.):S13-S19.
235. van de Wetering M, Sancho E, Verweij C, et al. The beta-catenin/TCF-4 complex
imposes a crypt progenitor phenotype on colorectal cancer cells. Cell . 2002;111
(2):241-250.
236. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon car-
cinoma cells. Nature . 1999;398(6726):422-426.
237. Crawford HC, Fingleton B, GustavsonMD, et al. The PEA3 subfamily of Ets transcrip-
tion factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in
intestinal tumors. Mol Cell Biol . 2001;21(4):1370-1383.
238. Mann B, Gelos M, Siedow A, et al. Target genes of beta-catenin-T cell-factor/
lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad
Sci USA . 1999;96(4):1603-1608.
239. Ahmed Y, Hayashi S, Levine A, Wieschaus E. Regulation of armadillo by a Drosophila
APCinhibits neuronal apoptosis during retinal development. Cell . 1998;93(7):1171-1182.
240. Martinek S, Inonog S, Manoukian AS, Young MW. A role for the segment polarity
gene shaggy/GSK-3 in the Drosophila circadian clock. Cell . 2001;105(6):769-779.
241. Shimasaki T, Kitano A, Motoo Y, Minamoto T. Aberrant glycogen synthase kinase
3beta in the development of pancreatic cancer. J Carcinog . 2012;11:15.
242. Shimura T. Acquired radioresistance of cancer and the AKT/GSK3beta/cyclin D1
overexpression cycle. J Radiat Res . 2011;52(5):539-544.
243. Iitaka C, Miyazaki K, Akaike T, Ishida N. A role for glycogen synthase kinase-3beta in
the mammalian circadian clock. J Biol Chem . 2005;280(33):29397-29402.
244. Kondratov RV, Shamanna RK, Kondratova AA, Gorbacheva VY, Antoch MP. Dual
role of the CLOCK/BMAL1 circadian complex in transcriptional regulation. FASEB
J . 2006;20(3):530-532.
245. Doi M, Takahashi Y, Komatsu R, et al. Salt-sensitive hypertension in circadian clock-
deficient Cry-null mice involves dysregulated adrenal Hsd3b6. Nat Med . 2010;16
(1):67-74.
246. Hua H, Wang Y, Wan C, et al. Circadian gene mPer2 overexpression induces cancer
cell apoptosis. Cancer Sci . 2006;97(7):589-596.
247. Relles D, Sendecki J, Chipitsyna G, Hyslop T, Yeo CJ, Arafat HA. Circadian gene
expression and clinicopathologic correlates in pancreatic cancer. J Gastrointest Surg .

2013;17(3):443-450.
248. Lindahl T, Barnes DE. Repair of endogenous DNA damage. Cold Spring Harb Symp
Quant Biol . 2000;65:127-133.
249. Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature . 2004;432

(7015):316-323.
250. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science .

1995;267(5203):1456-1462.
251. Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular
autophosphorylation and dimer dissociation. Nature . 2003;421(6922):499-506.
252. Cimprich KA, Shin TB, Keith CT, Schreiber SL. cDNA cloning and gene mapping of
a candidate human cell cycle checkpoint protein. Proc Natl Acad Sci USA . 1996;93
(7):2850-2855.
253. el-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53
tumor suppression. Cell . 1993;75(4):817-825.
254. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting pro-
tein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell . 1993;75(4):805-816.
255. Rich T, Allen RL, Wyllie AH. Defying death after DNA damage. Nature . 2000;407
(6805):777-783.